Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$394M |
| 2 |
JPMorgan Chase
JPM
|
+$274M |
| 3 |
Quest Diagnostics
DGX
|
+$268M |
| 4 |
Moody's
MCO
|
+$198M |
| 5 |
UPL
Ultra Petroleum Corp. Common Stock
UPL
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$1.02B |
| 2 |
Progressive
PGR
|
+$670M |
| 3 |
Canadian Natural Resources
CNQ
|
+$548M |
| 4 |
Labcorp
LH
|
+$291M |
| 5 |
EOG Resources
EOG
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.39% |
| 2 | Healthcare | 12.23% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Technology | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFM
126
DELISTED
Whole Foods Market Inc
WFM
| $9.69M | 0.03% |
250,884
+115,140
| +85% | +$5.02M |
|
127
Masco
MAS
$14.5B
| $9.53M | 0.03% |
488,407
| – | – |
|
128
Nike
NKE
$60.5B
| $9.49M | 0.03% |
244,642
+3,740
| +2% | +$139K |
|
129
NetEase
NTES
$82.1B
| $9.47M | 0.03% |
604,250
+1,200
| +0.2% | +$17.1K |
|
130
GE Aerospace
GE
$361B
| $8.89M | 0.03% |
70,595
-70
| -0.1% | -$8.9K |
|
|
IRF
131
DELISTED
INTL RECTIFIER CORP
IRF
| $8.63M | 0.03% |
309,390
| – | – |
|
|
UN
132
DELISTED
Unilever NV New York Registry Shares
UN
| $8.59M | 0.03% |
196,426
-110,760
| -36% | -$4.75M |
|
133
Tyson Foods
TSN
$20.6B
| $8.36M | 0.02% |
222,810
-23,700
| -10% | -$950K |
|
134
Highwoods Properties
HIW
$3.46B
| $8.33M | 0.02% |
+198,537
| New | +$7.99M |
|
135
Regency Centers
REG
$13.9B
| $8.32M | 0.02% |
149,497
| – | – |
|
136
Salesforce
CRM
$171B
| $7.91M | 0.02% |
136,227
+12,396
| +10% | +$670K |
|
|
AES.PRC.CL
137
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
| $7.52M | 0.02% |
145,027
| – | – |
|
138
Applied Materials
AMAT
$391B
| $7.45M | 0.02% |
330,324
+6,035
| +2% | +$123K |
|
|
ALEX
139
DELISTED
Alexander & Baldwin
ALEX
| $7.21M | 0.02% |
174,070
+69,196
| +66% | +$2.73M |
|
|
FCS
140
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $7.18M | 0.02% |
460,527
| – | – |
|
|
SVA
141
DELISTED
Sinovac Biotech, Ltd
SVA
| $7.05M | 0.02% |
1,250,546
+6,340
| +0.5% | +$38.5K |
|
142
Sherwin-Williams
SHW
$84.1B
| $6.8M | 0.02% |
98,550
+960
| +1% | +$64.1K |
|
143
ICICI Bank
IBN
$107B
| $6.77M | 0.02% |
746,664
-199,446
| -21% | -$1.72M |
|
144
AES
AES
$10.5B
| $6.48M | 0.02% |
416,466
| – | – |
|
145
SBA Communications
SBAC
$19.4B
| $6.47M | 0.02% |
63,207
+14,092
| +29% | +$1.35M |
|
146
Freeport-McMoran
FCX
$110B
| $6.44M | 0.02% |
176,464
| – | – |
|
147
Elevance Health
ELV
$86.9B
| $6.14M | 0.02% |
57,098
-29,949
| -34% | -$3.09M |
|
148
Expeditors International
EXPD
$24.4B
| $5.68M | 0.02% |
128,680
-191,773
| -60% | -$8.25M |
|
149
Intel
INTC
$476B
| $5.51M | 0.02% |
178,377
+2,323
| +1% | +$63.7K |
|
150
TJX Companies
TJX
$155B
| $5.45M | 0.02% |
204,986
+2,064
| +1% | +$58.9K |
|
Similar funds
Christopher Davis's Q2 2014 Portfolio in Review
As of Q2 2014, Christopher Davis held 188 positions worth $33.6B, down 7.4% from $36.3B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Christopher Davis withdrew a net $4.12B in Q2 2014, closing 8 positions and reducing 79 holdings. Its most notable exit was Bed Bath & Beyond Inc, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Christopher Davis opened a new position in Moody's worth $211M.
- Christopher Davis's largest Q2 2014 buy was Moody's: 2,406,257 shares worth $211M.
- Christopher Davis added most to Amazon in Q2 2014, an estimated $394M increase.
- Christopher Davis's biggest Q2 2014 reduction was Progressive, cutting an estimated $670M.
- Christopher Davis fully exited Bed Bath & Beyond Inc in Q2 2014, selling an estimated $1.02B.
- Christopher Davis's ten largest holdings make up 48% of its $33.6B portfolio in Q2 2014.
- Christopher Davis opened 13 new positions and closed 8 in Q2 2014.
- Christopher Davis's portfolio value fell 7.4% quarter-over-quarter to $33.6B.
Based on Davis Selected Advisers's 13F filing for Q2 2014, filed 13 Aug 2014.